Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Trading Update On One Tobacco Stock - BATS

Jun 27, 2024 | Team Kalkine
Trading Update On One Tobacco Stock - BATS

  • BATS:LSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

British American Tobacco PLC  

British American Tobacco PLC (LSE: BATS) is an FTSE 100 index-listed entity focused on manufacturing and selling cigarettes, tobacco, and other nicotine products internationally. The company distributes its products to retail outlets across the U.S., Europe, and North Africa (ENA), Americas and Sub-Saharan Africa (AMSSA), and the Asia Pacific and Middle East (APME) regions. The Company operates through the retail of homewares in the United Kingdom segment.

Trading Update (Released on 04 June 2024)

  • Financial Update: The group is on track to meet the FY24 guidance, with H1FY24 results are expected to be close to the expectations. The company anticipates H2 FY24 acceleration driven by the rollout of innovations in New Categories and the positive impact of H1 FY24 investments in U.S. commercial actions and related wholesaler inventory movements.
  • Operational Highlights: Group cigarette volume share in key markets increased by 30 bps, while value share decreased by 10 bps due to adverse geographical mix and U.S. commercial plans. Despite early signs of U.S. economic recovery, consumer spending remains stretched, with combustible industry volume down about 9% YTD. The management maintained global value share leadership at 41.1%, with gains in AME (up 20 bps) offset by a decline in the U.S. (down 90 bps).
  • Outlook: Global tobacco industry volume is expected to decline by approximately 3% as per the management. The company anticipates low-single-figure organic constant currency revenue growth, with a stronger focus on New Category growth in H2 FY24. Adjusted profit from operations is also expected to grow in the low single figures, despite a 2% transactional FX headwind and Group revenue and profit growth will be weighted towards H2 FY24. There is an expected 4% translational FX headwind on adjusted profit from operations growth for both the H2 FY24 and FY24 overall. Operating cash flow conversion is anticipated to exceed 90%.

Share Price Chart

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

British American Tobacco PLC (LSE: BATS) was trading at the current market price of GBX 2,459.00 (as of 27 June 2024, 09:05 AM, GMT+1)

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 27 June 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Note 4: Dividend Yield may vary as per the stock price movement.


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions